Medtronic Stock Falls Despite Strong Q4 Earnings and Dividend Hike
TL;DR Summary
Medtronic's stock fell 2.8% despite beating earnings expectations due to underwhelming year-over-year sales growth and a significant drop in GAAP earnings. Investors are concerned about the company's high valuation and modest growth forecast for fiscal 2025, leading to a sell-off.
- Why Medtronic Stock Slumped Today Yahoo Finance
- Medtronic (MDT) Q4 2024 Earnings Call Transcript The Motley Fool
- Medtronic’s stock drops after profit beats again but outlook disappoints MarketWatch
- Medtronic's Q4 Earnings: Medical Device Giant Clocks Strong Sales From Neurology Devices, Hikes Dividend Yahoo Finance
- Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase Medtronic
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
92%
501 → 40 words
Want the full story? Read the original article
Read on Yahoo Finance